Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 12:31 AM
NCT ID:
NCT00739167
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of primary hepatocellular cancer or metastatic liver cancer
* Planning radioembolization or transcatheter arterial embolization using yttrium Y 90 glass microspheres
* No encephalopathy
PATIENT CHARACTERISTICS:
* ECOG performance status 0-2
* Bilirubin ≤ 3 mg/dL
* Able to comply with study procedures
PRIOR CONCURRENT THERAPY:
* No prior treatment with radioembolization or transcatheter arterial embolization
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00739167
Study Brief:
Protocol Section:
NCT00739167